Zackrisson G, Taranger J, Trollfors B
Department of Clinical Bacteriology, University of Göteborg, Sweden.
J Pediatr. 1990 Feb;116(2):190-4. doi: 10.1016/s0022-3476(05)82873-2.
The aim of this study was to examine whether there is a correlation between parental information on the child's history of whooping cough and the presence or absence of serum antibodies against two antigens of Bordetella pertussis, pertussis toxin and filamentous hemagglutinin, in nonvaccinated Swedish children. The parents of 266 Swedish children aged 1 to 4 years answered a questionnaire regarding the child's history of whooping cough, and a serum sample was obtained from the child for determination of IgG, IgM, and IgA antibodies to pertussis toxin and filamentous hemagglutinin. The study was performed from 1984 to 1986, five to seven years after the cessation of general vaccination against pertussis in Sweden; none of the children had received pertussis vaccine. Antibodies to both toxin and filamentous hemagglutinin increased with age. Of the children aged 4 years, 50% had antibodies to both antigens. Of all 266 children, 100 had antibodies to both antigens, 6 to toxin alone, and 49 to filamentous hemagglutinin alone. There was a good correlation between the presence of antibodies and a history of whooping cough. Of 91 children with a history of whooping cough, 77 had antibodies against both antigens and 13 against one antigen; only one child lacked detectable antibodies against both antigens. Of the 175 children with no history of whooping cough, 110 lacked detectable antibodies to both antigens, 23 had antibodies to both, 2 to toxin alone, and 40 to filamentous hemagglutinin alone. The data indicate that parental information on a previous history of whooping cough in their nonimmunized child is reliable, and that many infections with B. pertussis are subclinical or atypical. Exposure to other Bordetella species than B. pertussis, which is the only toxin-producing species, might be important for the development of FHA antibodies. A follow-up 2 to 4 years after the collection of serum samples of children without a history of whooping cough but with antibodies to one or both antigens indicated that serum antibodies to toxin, but not to filamentous hemagglutinin, may be protective against disease.
本研究的目的是调查在未接种疫苗的瑞典儿童中,父母提供的关于孩子百日咳病史的信息与针对百日咳博德特氏菌两种抗原(百日咳毒素和丝状血凝素)的血清抗体的有无之间是否存在相关性。266名1至4岁瑞典儿童的父母回答了一份关于孩子百日咳病史的问卷,并采集了孩子的血清样本,以测定针对百日咳毒素和丝状血凝素的IgG、IgM和IgA抗体。该研究于1984年至1986年进行,此时距离瑞典停止普遍接种百日咳疫苗已有五至七年;所有儿童均未接种过百日咳疫苗。针对毒素和丝状血凝素的抗体均随年龄增长而增加。4岁儿童中,50%对两种抗原均有抗体。在所有266名儿童中,100名对两种抗原均有抗体,6名仅对毒素有抗体,49名仅对丝状血凝素有抗体。抗体的存在与百日咳病史之间存在良好的相关性。在91名有百日咳病史的儿童中,77名对两种抗原均有抗体,13名对一种抗原有抗体;只有一名儿童两种抗原均未检测到抗体。在175名无百日咳病史的儿童中,110名两种抗原均未检测到抗体;23名对两种抗原均有抗体,2名仅对毒素有抗体,40名仅对丝状血凝素有抗体。数据表明,父母提供的关于其未免疫孩子既往百日咳病史的信息是可靠的,并且许多百日咳博德特氏菌感染是亚临床性或非典型的。接触除百日咳博德特氏菌(唯一产生毒素的菌种)以外的其他博德特氏菌属菌种,可能对丝状血凝素抗体的产生很重要。对无百日咳病史但对一种或两种抗原均有抗体的儿童在采集血清样本后2至4年进行的随访表明,针对毒素而非丝状血凝素的血清抗体可能对疾病具有保护作用。